FDA approves new blood test for Alzheimer’s disease
World2 sources1 country🔦 Under-reported5m ago
The U.S. Food and Drug Administration (FDA) has granted approval for a new blood test designed to aid in the diagnosis of Alzheimer’s disease. Developed by Roche, the Elecsys Phospho-Tau blood test is the latest diagnostic tool to receive regulatory clearance for this purpose.
This development marks the fourth time the FDA has approved a blood test for Alzheimer’s disease within the last two years. The approval represents a continued trend in the availability of blood-based diagnostic options for the condition.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
The HillIdentifies the specific manufacturer and product name involved in the approval.
Newz